Amrofec SR 100mg Tablets | Amros Pharmaceuticals

Description

Amrofec SR 100mg Tablets are labeled as a sustained-release diclofenac formulation.

Diclofenac is a nonsteroidal anti-inflammatory drug that reduces prostaglandin synthesis, helping alleviate inflammation, pain and swelling.

Confirmed diclofenac sodium extended-release 100mg formulations are indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

The sustained-release formulation is designed to provide extended delivery of the active ingredient. Its release characteristics must be verified against Amrofec SR’s approved formulation before making claims about prolonged drug action or dosing frequency.

Verified Prescription Information

Indications: Osteoarthritis and rheumatoid arthritis for the referenced diclofenac sodium extended-release 100mg formulation.

Dosage & Administration: The reference adult dosage is 100mg once daily for osteoarthritis or rheumatoid arthritis. Exceptional higher dosing requires careful evaluation of risks and benefits. This dosing information must not be assigned to Amrofec SR until its formulation is confirmed.

Possible Side Effects: Nausea, abdominal discomfort, headache, dizziness and fluid retention. Serious gastrointestinal, cardiovascular, renal and hepatic adverse effects may occur.

Contraindications & Precautions: NSAID hypersensitivity, aspirin-sensitive asthma and perioperative use around coronary artery bypass graft surgery. Extended-release diclofenac formulations are not necessarily interchangeable with enteric-coated formulations.